176 related articles for article (PubMed ID: 8070858)
1. Use of haemoglobin adducts for biomonitoring exposure to 1,3-butadiene.
Osterman-Golkar SM; Bond JA; Ward JB; Legator MS
IARC Sci Publ; 1993; (127):127-34. PubMed ID: 8070858
[TBL] [Abstract][Full Text] [Related]
2. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene.
Osterman-Golkar SM; Moss O; James A; Bryant MS; Turner M; Bond JA
Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466
[TBL] [Abstract][Full Text] [Related]
3. Biological monitoring of 1,3-butadiene: species differences in haemoglobin binding in rat and mouse.
Albrecht OE; Filser JG; Neumann HG
IARC Sci Publ; 1993; (127):135-42. PubMed ID: 8070859
[TBL] [Abstract][Full Text] [Related]
4. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
Booth ED; Kilgour JD; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
[TBL] [Abstract][Full Text] [Related]
5. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
6. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
8. Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides.
Pérez HL; Lähdetie J; Landin H; Kilpeläinen I; Koivisto P; Peltonen K; Osterman-Golkar S
Chem Biol Interact; 1997 Aug; 105(3):181-98. PubMed ID: 9291996
[TBL] [Abstract][Full Text] [Related]
9. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
10. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
[TBL] [Abstract][Full Text] [Related]
11. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide.
Fred C; Grawé J; Törnqvist M
Mutat Res; 2005 Aug; 585(1-2):21-32. PubMed ID: 15925539
[TBL] [Abstract][Full Text] [Related]
14. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
15. Assessment of environmental and occupational exposures to butadiene as a model for risk estimation of petrochemical emissions.
Sorsa M; Peltonen K; Anderson D; Demopoulos NA; Neumann HG; Osterman-Golkar S
Mutagenesis; 1996 Jan; 11(1):9-17. PubMed ID: 8671709
[TBL] [Abstract][Full Text] [Related]
16. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans.
Bond JA; Csanády GA; Leavens T; Medinsky MA
IARC Sci Publ; 1993; (127):45-55. PubMed ID: 8070886
[TBL] [Abstract][Full Text] [Related]
17. Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Boysen G; Georgieva NI; Upton PB; Jayaraj K; Li Y; Walker VE; Swenberg JA
Cancer Res; 2004 Dec; 64(23):8517-20. PubMed ID: 15574756
[TBL] [Abstract][Full Text] [Related]
18. Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice.
Laib RJ; Filser JG; Kreiling R; Vangala RR; Bolt HM
Environ Health Perspect; 1990 Jun; 86():57-63. PubMed ID: 2401272
[TBL] [Abstract][Full Text] [Related]
19. Species differences in the metabolism of 1,3-butadiene in vivo.
Henderson RF; Bechtold WE; Sabourin PJ; Maples KR; Dahl AR
IARC Sci Publ; 1993; (127):57-64. PubMed ID: 8070887
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hemoglobin adduct formation in mice and rats after administration of [14C]butadiene or [14C]isoprene.
Sun JD; Dahl AR; Bond JA; Birnbaum LS; Henderson RF
Toxicol Appl Pharmacol; 1989 Aug; 100(1):86-95. PubMed ID: 2763304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
